Insider Transactions Reported by 14 Insiders of Renalytix plc

Symbol
RNLXY, RENXF on OTC
Location
London

There are no Buy or Sell transactions made by insiders since 27 Dec 2024

Renalytix plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 10%+ Owner $3.79M 01 Nov 2024
CHRISTOPHER MILLS Director, 10%+ Owner $2.52M 20 Nov 2023
James Renwick McCullough Chief Executive Officer, Director $687K 06 Jul 2023
O. James Sterling Chief Financial Officer $451K 06 Jul 2023
Fergus Fleming Chief Technical Officer, Director $142K 06 Jul 2023
Scannell Timothy J Director $17.2K 01 Jul 2023
THOMAS H. MCLAIN President $14.8K 10 Jul 2023
Catherine Coste Director 20 Nov 2023
Erik Lium Director 01 Jul 2023
Michael J. Donovan Chief Medical Officer 06 Jul 2023
Joel R. Jung Interim Chief Financial Office 11 Jun 2024
Chirag R. Parikh Director 20 Nov 2023
Howard Doran JR Chief Business Officer 20 Nov 2023
DANIEL J. LEVANGIE Director 20 Nov 2023

Recent Insider Transactions by Companies or Individuals for Renalytix plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.